248 related articles for article (PubMed ID: 24402045)
1. Overexpression of cysteine cathepsin L is a marker of invasion and metastasis in ovarian cancer.
Zhang W; Wang S; Wang Q; Yang Z; Pan Z; Li L
Oncol Rep; 2014 Mar; 31(3):1334-42. PubMed ID: 24402045
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma.
Niedergethmann M; Wostbrock B; Sturm JW; Willeke F; Post S; Hildenbrand R
Pancreas; 2004 Oct; 29(3):204-11. PubMed ID: 15367886
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis.
Zhang W; Yang HC; Wang Q; Yang ZJ; Chen H; Wang SM; Pan ZM; Tang BJ; Li QQ; Li L
Anticancer Res; 2011 Oct; 31(10):3423-8. PubMed ID: 21965756
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between cathepsin L and invasion and metastasis of ovarian carcinoma cells].
Wang SM; Li L; Zhang W; Li DR; Tang BJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):598-602. PubMed ID: 21029616
[TBL] [Abstract][Full Text] [Related]
5. Cathepsins B and L in peripheral blood mononuclear cells of pediatric acute myeloid leukemia: potential poor prognostic markers.
Jain M; Bakhshi S; Shukla AA; Chauhan SS
Ann Hematol; 2010 Dec; 89(12):1223-32. PubMed ID: 20567828
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of cathepsin L and cathepsin B in dilated cardiomyopathy.
Mehra S; Kumar M; Manchanda M; Singh R; Thakur B; Rani N; Arava S; Narang R; Arya DS; Chauhan SS
Mol Cell Biochem; 2017 Apr; 428(1-2):139-147. PubMed ID: 28074340
[TBL] [Abstract][Full Text] [Related]
7. CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L.
Mao Z; Sang MM; Chen C; Zhu WT; Gong YS; Pei DS
Int J Biol Sci; 2019; 15(6):1310-1324. PubMed ID: 31223289
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin L is involved in proliferation and invasion of ovarian cancer cells.
Zhang L; Wei L; Shen G; He B; Gong W; Min N; Zhang L; Duan Y; Xie J; Luo H; Gao X
Mol Med Rep; 2015 Jan; 11(1):468-74. PubMed ID: 25333746
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Cathepsin L is associated with chemoresistance and invasion of epithelial ovarian cancer.
Sui H; Shi C; Yan Z; Wu M
Oncotarget; 2016 Jul; 7(29):45995-46001. PubMed ID: 27351223
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors.
Kawasaki G; Kato Y; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Apr; 93(4):446-54. PubMed ID: 12029284
[TBL] [Abstract][Full Text] [Related]
11. Expression and Clinical Implications of Cysteine Cathepsins in Gallbladder Carcinoma.
Mehra S; Panwar R; Thakur B; Yadav R; Kumar M; Singh R; Dash NR; Sahni P; Chauhan SS
Front Oncol; 2019; 9():1239. PubMed ID: 31824841
[No Abstract] [Full Text] [Related]
12. Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo.
Menzel K; Hausmann M; Obermeier F; Schreiter K; Dunger N; Bataille F; Falk W; Scholmerich J; Herfarth H; Rogler G
Clin Exp Immunol; 2006 Oct; 146(1):169-80. PubMed ID: 16968411
[TBL] [Abstract][Full Text] [Related]
13. Plasma cathepsin L: a prognostic marker for pancreatic cancer.
Singh N; Das P; Gupta S; Sachdev V; Srivasatava S; Datta Gupta S; Pandey RM; Sahni P; Chauhan SS; Saraya A
World J Gastroenterol; 2014 Dec; 20(46):17532-40. PubMed ID: 25516668
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of cathepsin L: a novel independent prognostic marker of worse outcome in hepatocellular carcinoma patients.
Ruan J; Zheng H; Fu W; Zhao P; Su N; Luo R
PLoS One; 2014; 9(11):e112136. PubMed ID: 25384089
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.
Niedergethmann M; Hildenbrand R; Wolf G; Verbeke CS; Richter A; Post S
Int J Pancreatol; 2000 Aug; 28(1):31-9. PubMed ID: 11185708
[TBL] [Abstract][Full Text] [Related]
16. High Expression of Cullin7 Correlates with Unfavorable Prognosis in Epithelial Ovarian Cancer Patients.
Xi J; Zeng ST; Guo L; Feng J
Cancer Invest; 2016; 34(3):130-6. PubMed ID: 26962950
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin L in tumor angiogenesis and its therapeutic intervention by the small molecule inhibitor KGP94.
Sudhan DR; Rabaglino MB; Wood CE; Siemann DW
Clin Exp Metastasis; 2016 Jun; 33(5):461-73. PubMed ID: 27055649
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
Hu X; Li D; Zhang W; Zhou J; Tang B; Li L
Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979
[TBL] [Abstract][Full Text] [Related]
20. The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer.
Nishikawa H; Ozaki Y; Nakanishi T; Blomgren K; Tada T; Arakawa A; Suzumori K
Gynecol Oncol; 2004 Mar; 92(3):881-6. PubMed ID: 14984956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]